Nuage Therapeutics

Nuage Therapeutics is a pharmaceutical company dedicated to developing selective and potent drugs that target intrinsically disordered proteins, which are often associated with challenging medical conditions. The company employs innovative approaches in chemical biology and biomolecular condensation to create selective inhibitors aimed at treating diseases such as castration-resistant prostate cancer. By focusing on these complex and often "undruggable" protein targets, Nuage Therapeutics aims to address significant unmet medical needs and improve patient outcomes through targeted therapeutic solutions.